Measuring tumor metabolism by 18F-FDG PET predicts outcome in a multicenter study: a step off in the right direction

J Nucl Med. 2015 Jan;56(1):1-2. doi: 10.2967/jnumed.114.151175.
No abstract available

Publication types

  • Research Support, American Recovery and Reinvestment Act
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / drug therapy*
  • Female
  • Fluorodeoxyglucose F18 / metabolism*
  • Humans
  • Positron-Emission Tomography*
  • Receptor, ErbB-2 / metabolism*

Substances

  • Antineoplastic Agents
  • Fluorodeoxyglucose F18
  • ERBB2 protein, human
  • Receptor, ErbB-2